• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Tainted valsartan has been on the market for 4 years, FDA discovers fiercebiotech
    August 08, 2018
    China’s Zhejiang Huahai Pharmaceutical set off a global recall after it informed global regulators last month that it had discovered the suspected cancer causing impurity N-nitrosodimethylamine in its valsartan API after changing its manufacturing process

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service